Omnos Ltd.

Omnos Ltd. is a United Kingdom-based company described in public data as supplying personalised health information. It operates in the health-technology and diagnostics space, connecting individuals and healthcare practitioners with testing, interpretation and personalised health insights. The company is associated with the Regenerus Labs platform, an all-in-one service and community for healthcare practitioners that provides access to a broad range of in vitro diagnostic tests alongside clinical interpretation, education and patient-management tools. Regenerus Labs positions itself as more than a testing provider: it supports practitioners across the clinical journey, from test selection and interpretation to education, service delivery and ongoing patient care. Its stated vision is to shape the future of personalised healthcare, and its mission is to empower practitioners to deliver faster, more accurate care through technology, tools and resources. The platform combines one of the broadest ranges of in vitro diagnostic tests in the UK with a service model designed for real clinical practice. Typical offerings include functional and diagnostic tests such as the OM16 Wellness 360 Male panel, which assesses 63 biomarkers covering organ function, hormonal health and stress levels, and the CMI30 Organic Acids Test (OAT), which provides metabolic insights. These tests are delivered through partner laboratories including Eurofins and Mosaic Diagnostics, and cover areas such as nutrition and toxic elements, fatigue, nutrient status, detoxification and blood sugar regulation. Omnos Ltd. is a private company; no parent company, ownership structure or stock listing is indicated in the available evidence. Its public footprint centres on the Regenerus Labs brand and its practitioner community, with a crowdfunding campaign hosted on Crowdcube aimed at advancing the platform and building a global network to transform healthcare.

Omnos Ltd. is a United Kingdom company that public data describes as supplying personalised health information. Its commercial activity is closely tied to the Regenerus Labs platform, which serves healthcare practitioners with diagnostic testing, clinical interpretation and practice-support tools. Regenerus Labs has built its offering around evidence-based diagnostics and personalised care. According to its own materials, the platform was created to address common problems in healthcare: long waits, overlooked symptoms and a noisy media environment filled with misinformation. Its stated aim is to bridge the gap between patients and trusted healthcare practitioners so that people can take control of their health. The platform combines access to one of the broadest ranges of in vitro diagnostic tests in the UK with a service model designed for real clinical practice. It supports practitioners at every stage of the clinical journey, from test selection and interpretation to education, service delivery and ongoing patient care. Its Learning Hub provides a library with thousands of hours of clinically relevant content, including webinars, events and self-paced courses. Practitioners also receive dedicated clinical support, personalised one-to-one guidance, responsive account management and centralised patient and order management. Regenerus Labs offers a comprehensive series of functional tests. Examples include the OM16 Wellness 360 Male panel, which assesses 63 biomarkers covering vital organ function, hormonal health and stress levels, and the CMI30 Organic Acids Test (OAT), which provides metabolic insights. Tests are delivered through partner laboratories such as Eurofins and Mosaic Diagnostics, and cover areas including nutrition and toxic elements, fatigue, nutrient status, detoxification and blood sugar regulation. The company has sought to grow its platform through community investment, hosting a crowdfunding campaign on Crowdcube with the stated goal of advancing the platform and building a global network to transform healthcare. No founding date, founder names, headquarters location, parent company or stock listing are provided in the available evidence.

An all-in-one platform and community for healthcare practitioners, combining a broad range of in vitro diagnostic tests with clinical interpretation, education and patient-management support to advance personalised healthcare.

• OM16 Wellness 360 Male panel

  A comprehensive analysis assessing 63 biomarkers covering vital organ function, hormonal health and stress levels. Delivered via blood (venous) testing and covering organs health, sex hormones, detoxification, nutrient status and blood sugar regulation.

• CMI30 Organic Acids Test (OAT)

  A urine test providing metabolic insights, covering nutrition and toxic elements, fatigue and nutrient status.

1. 1Regenerus Labs | Homeregeneruslabs.com
2. 2Regenerus Labs | Aboutregeneruslabs.com
3. 3Omnos Ltd. - Wikidatawikidata.org